Unter den Marken unserer mehr als 25 Partner sticht TargetMol hervor

<p>2'-Hydroxy-4'-methylacetophenone, a phenolic compound isolated from Angelicae koreana roots possesses acaricidal property.</p>

<p>2,2'-Bipyridine is a unique bioactive natural product molecular scaffold commonly used in the core structure of many chelating ligands. 2,2'-Bipyridine acts as a bridge in the arrangement of the catalytic center. 2,2'-Bipyridine has good redox stability and glycemic activity.</p>

<p>Compound Fr14428 is a useful organic compound for research related to life sciences. The catalog number is Fr14428 and the CAS number is 2458-12-0.</p>

<p>p-Toluic Acid (4-Methylbenzoic acid) belongs to the class of organic compounds known as benzoic acids. p-Toluic Acid has been primarily detected in saliva.</p>

<p>Compound Fr14500 is a natural product for research related to life sciences. The catalog number is Fr14500 and the CAS number is 14667-55-1.</p>

Pyrazinamine: synthetic intermediate for research, used as a reagent in biochemistry and physiology.

<p>2,4-Dimethylthiazole can be used as a raw material for insecticides and fungicides to control crop pests and diseases.</p>

<p>2,6-Dimethylaniline Hydrochloride is a useful organic compound for research related to life sciences.The CAS number is 21436-98-6.</p>

Lupinine: alkaloid, counters ethanol anesthesia, inhibits AChE/BChE, may activate CD69, found in Loranthus/Calia/Lupinus, could inhibit heparin.

Lupinine hydrochloride is a bioactive chemical.

<p>Compound Fr16621, with CAS No. 580-22-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr16621 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.</p>

<p>3, 4-dihydro-2h-Pyrido [3,2-b][1,4]oxazine has potential applications in the study of bioactive compounds.</p>

4-(Imidazol-1-yl)phenol is a potent signal enhancer in horseradish peroxidase (HRP)–luminol chemiluminescence (CL) immunoassays [1].

<p>Compound Fr16683 is a natural product for research related to life sciences. The catalog number is Fr16683 and the CAS number is 699-83-2.</p>

Compound Fr16695, with CAS No. 695-34-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr16695 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

<p>Oxindole (Indolin-2-one) is an aromatic heterocyclic building block.</p>

<p>4-Hydroxybenzyl cyanide (4-Hydroxyphenylacetonitrile) shows strong antioxidative activity.</p>

<p>2-Methyl-2H-indazole-3-carboxylic acid can be used as a potentially active molecular skeleton for the design and synthesis of biologically active compounds.</p>

<p>4-ACETAMIDOANTIPYRINE, with CAS No. 83-15-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 4-ACETAMIDOANTIPYRINE provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.</p>

N-Methyl-1,3-benzoxazol-2-amine, with CAS No. 19776-98-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. N-Methyl-1,3-benzoxazol-2-amine provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

<p>1,2,3,4-Tetrahydro-6-quinolinecarboxylic Acid is a useful organic compound for research related to life sciences. The catalog number is Fr21307 and the CAS number is 5382-49-0.</p>

<p>A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS);</p>

<p>3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);</p>

A unique collection of xnum EMA-approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 343 protease and proteasome inhibitors for research in chemical genomics, and drug screening;

<p>A unique collection of xnum microtubule-targeted compounds can be used in HTS and HCS;</p>

<p>xnum well-chosen unique AMPK-targeted small molecules；</p>

Well-chosen 953 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new

<p>A unique collection of 420 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with</p>

<p>A unique collection of 759 cytoskeleton-related compounds, can be used for HTS and HCS；</p>

<p>Well-chosen xnum compounds with unique structures targeting transcription factor;</p>

<p>A unique collection of 365 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;</p>

<p>A unique collection of xnum GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target</p>

<p>A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening;</p>

Membrane proteins are a class of proteins widely found in biological cell membranes, playing essential roles in the structure and function of cells. Based on their location and function, membrane proteins can be classified into three main categories: peripheral membrane proteins, integral membrane proteins, and lipid-anchored proteins. Membrane proteins encompass a variety of functional proteins, including glycoproteins, carrier proteins, and enzymes. They are often linked to carbohydrate molecules, which can transmit signals into the cell by undergoing structural changes, participating in signal transduction processes. Membrane proteins perform a range of critical functions, including substance transport, signal transduction, cell recognition, and energy conversion. In drug development, membrane proteins, especially G protein-coupled receptors (GPCRs), ion channels, and transporters, are of particular interest. Many diseases are related to the malfunction of specific membrane proteins. Therefore, drugs designed to target these proteins can regulate their activity, aiming to treat diseases. TargetMol has collected 6422 compounds that target membrane proteins, which can be used for membrane protein-related scientific research and drug screening, suitable for high-throughput and high-content screening.

<p>A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;</p>

<p>A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.</p>

<p>Contains xnum active small molecules for research related to post-translational modifications (PTMs);</p>

<p>A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;</p>

A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents；

<p>A unique collection of xnum nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-</p>

<p>A unique collection of xnum anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-</p>

<p>A unique collection of xnum diabetes related compounds;</p>

<p>A unique collection of 8328 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs;</p>

<p>A collection of xnum highly selective inhibitors</p>

<p>A unique collection of xnum compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS</p>

<p>A unique collection of 406 cancer cell differentiation inducing compounds for high throughput and high content screening;</p>

<p>A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);</p>

48 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

<p>xnum tumor-targeted drugs that can be used for high-throughput and high-content screening.</p>

<p>A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；</p>

<p>A unique collection of 1702 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung</p>

<p>A unique collection of 1939 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-</p>

<p>A unique collection of 2238 pancreatic cancer related compounds can be used in HTS and HCS;</p>

<p>xnum species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.</p>

<p>xnum compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.</p>

<p>2070 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.</p>

<p>A unique collection of xnum compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological</p>

<p>A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related</p>

<p>A unique collection of 931 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;</p>

<p>A unique collection of 784 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;</p>

<p>A collection of xnum selected human endogenous metabolites for high throughput and high content screening.</p>

<p>A unique collection of xnum endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening.</p>

<p>The TargetMol Bile Acids Compound Library carefully curates an xnum number of natural primary and secondary bile acids.</p>

<p>A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).</p>

<p>xnum glycometabolism-related comounds, can be used for HTS and HCT;</p>

<p>555 glycolysis-related active compounds for high-throughput and high-content screening.</p>

A unique collection of xnum mouse metabolites, which can be used for HTS and HCS;

<p>A unique collection of 614 gut microbial metabolites which can be used for HTS and HCS;</p>

<p>A unique collection of xnum glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is</p>

<p>A unique collection of xnum metabolic pathway-related bioactive small molecule compounds for high-throughput, high-content screening.</p>

<p>A unique collection of 4454 human metabolites for high-throughput, high-content screening.</p>

<p>A unique collection of xnum compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;</p>

<p>A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening；</p>

<p>A unique collection of xnum compounds related to neurodegenerative diseases can be used for HTS or HCS；</p>

<p>xnum compounds related to neuronal differentiation, suitable for the drug development of nervous system disease.</p>

<p>A unique collection of xnum bioactive small molecules with neuroprotective relevance for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of xnum pain-related compounds for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 193 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;</p>

A unique collection of xnum compounds targeting serotonin receptors for high throughput screening and high content screening;

<p>1264 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening.</p>

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system&#039;s ability to readily detoxify

<p>A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening;</p>

<p>A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and</p>

<p>A unique collection of xnum compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS</p>

<p>A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 701 preclinical compounds for high throughput screening (HTS) and high content screening (HCS);</p>

A unique collection of xnum histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);

<p>xnum methylation-related compounds that can be used for high-throughput and high-content screening.</p>

<p>A unique collection of xnum compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;</p>

<p>A unique collection of 252 JAK/STAT signaling targeted compounds for high throughput and high content screening;</p>

A unique collection of xnum compounds targeting NF-κB signaling for high throughput screening and high content screening;

<p>A unique collection of xnum DNA Damage &amp;amp; Repair related compounds for high throughput screening (HTS) and high content screening (HCS);</p>

<p>Offers xnum small molecules that enhance gene editing efficiency, suitable for high-throughput screening (HTS) and high-content screening (HCS);</p>

<p>A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and</p>

<p>A collection of xnum bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.</p>

<p>TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 9384 small molecules that are suitable for new drug development,</p>

<p>A unique collection of xnum TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;</p>

<p>It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties</p>

<p>A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 237 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;</p>

<p>A unique collection of xnum compounds with antibiotic activity for new antibacterial drug screening;</p>

<p>A unique collection of 252 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.</p>

<p>419 well-chosen unique anti-parasitic small molecules;</p>

A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

<p>Contains xnum types of compounds with activity against Gram-negative bacteria, suitable for high-throughput and high-content screening;</p>

<p>A unqie collection of xnum anti gram-positive bacteria compounds for high throughput screening (HTS) and high content screening (HCS);</p>

A unique collection of 3048 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);

<p>A unique collection of xnum anti-inflammation compounds effective for high throughput screening and high content screening.</p>

<p>xnum non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.</p>

<p>A unique collection of 1353 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high</p>

<p>A unique collection of 131 cardiotoxicity inducing compounds for toxicological study;</p>

<p>A unique collection of 574 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of xnum promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for</p>

<p>TargetMol offers xnum compounds targeting mitochondrial membrane proteins, suitable for high-throughput screening (HTS) and high-content screening (HCS).</p>

A collection of xnum compounds with potential or confirmed mitochondrial protective activity, suitable for high-throughput and high-content screening.

<p>A unique collection of xnum cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening；</p>

Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5000 compounds representing 5000 scaffolds；

<p>A unique collection of 246 fragment-like small molecules for FBDD;</p>

<p>A unique collection of 197 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);</p>

<p>A unique collection of 509 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);</p>